As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Jaguar Health, Inc. The largest reported stake is Joshua Mailman's, at 9.99%. 8 filings are on record since August 14, 2025 (Schedule 13G/A, September 24, 2026).
Sell to companies like Jaguar Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Joshua Mailman · Sole voting: 186,205 · Shared voting: 3,412 · Sole dispositive: 186,205 · Shared dispositive: 3,412 · SCHEDULE 13G/A, 2026-09-24
- · Reporting person: Lincoln Alternative Strategies LLC · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-02-10
- · Holder: Joshua Mailman · Percent: 8.4% · SCHEDULE 13G
- · Holder: Iliad Research & Trading, L.P. · Percent: 9.8% · Shares: 440,000 · SCHEDULE 13G
- · Holder: Streeterville Capital LLC · Percent: 0% · Shares: 0 · SCHEDULE 13G/A
Jaguar Health, Inc. has 8 Schedule 13D or 13G filings on record since 2025-08-14. 2 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 9.99% | 189,617 | SCHEDULE 13G/A, 2026-09-24 | 2026-09-12 | |
| Iliad Research & Trading, L.P. | 9.8% | 440,000 | SCHEDULE 13G, 2025-12-11 | 2025-12-11 |
| CVI Investments, Inc. | 4.6% | 164,204 | SCHEDULE 13G/A, 2025-11-07 | 2025-09-30 |
| Lincoln Alternative Strategies LLC | 0% | 0 | SCHEDULE 13G/A, 2026-02-10 | 2026-01-12 |
| Streeterville Capital LLC | 0% | 0 | SCHEDULE 13G/A, 2025-12-11 | 2025-12-11 |
Holding shares or following this stake? See who's behind Jaguar Health, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Jaguar Health, Inc. and the records around it.
Jaguar Health, Inc. elsewhere on the record
- Company profile and every filing Jul 2026
- Form D filing Jul 2026
- Form D filing Jul 2026
- Who owns it
Companies that share a holder
- Lincoln Alternative Strategies LLC also filed stake reports on 13 other companies: Celularity Inc (Feb 2026), Longeveron Inc. (Feb 2026), Bionano Genomics, Inc. (Sep 2025)
- Streeterville Capital LLC also filed stake reports on 29 other companies: Professional Diversity Network, Inc. (Oct 2026), Solowin Holdings, Ltd. (Oct 2026), Vivos Therapeutics, Inc. (Sep 2026)
- CVI Investments, Inc. also filed stake reports on 48 other companies: Pine Tree Acquisition Corp. (Oct 2026), Sunshine Biopharma Inc. (Oct 2026), Outlook Therapeutics, Inc. (Aug 2026)
Watch Jaguar Health, Inc.
Get an email when Jaguar Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Jaguar Health, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Jaguar Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Jaguar Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Joshua Mailman | 186,205 | 3,412 | 186,205 | 3,412 | SCHEDULE 13G/A, 2026-09-24 |
| Lincoln Alternative Strategies LLC | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-02-10 |
| Streeterville Capital LLC | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-12-11 |
| Streeterville Management, LLC | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-12-11 |
| John M. Fife | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2025-12-11 |
The latest filing identifies Jaguar Health, Inc. by CUSIP 47010C854 and gives its principal executive office as 200 Pine Street, Suite 400, San Francisco, CA 94104 (SCHEDULE 13G/A, 2026-09-24).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | CVI Investments, Inc. | 9.9% | SCHEDULE 13G/A |
| 2025-08-29 | Lincoln Alternative Strategies LLC | 18.92% | SCHEDULE 13G |
| 2025-11-07 | CVI Investments, Inc. | 4.6% | SCHEDULE 13G/A |
| 2025-12-11 | Iliad Research & Trading, L.P. | 9.8% | SCHEDULE 13G |
| 2025-12-11 | Streeterville Capital LLC | 0% | SCHEDULE 13G/A |
| 2026-01-05 | Joshua Mailman | 8.4% | SCHEDULE 13G |
| 2026-02-10 | Lincoln Alternative Strategies LLC | 0% | SCHEDULE 13G/A |
| 2026-09-24 | Joshua Mailman | 9.99% | SCHEDULE 13G/A |
Questions about who owns Jaguar Health, Inc.
Who owns Jaguar Health, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Jaguar Health, Inc.: Joshua Mailman (9.99%, Schedule 13G/A, filed 2026-09-24) and Iliad Research & Trading, L.P. (9.8%, Schedule 13G, filed 2025-12-11).
Who are the largest shareholders of Jaguar Health, Inc.?
By the share each holder's latest filing reports, the largest holders of Jaguar Health, Inc. on this page are Joshua Mailman (9.99%) and Iliad Research & Trading, L.P. (9.8%).
When did Joshua Mailman buy into Jaguar Health, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Joshua Mailman on this page is the Schedule 13G, filed 2026-01-05, reporting 8.4%; its latest, Schedule 13G/A filed 2026-09-24, reports 9.99%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 8 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Jaguar Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 1, 2026 | Form D, private offering | $2M sold | Form D page | Source |
| July 1, 2026 | Form D, private offering | $40.80M sold | Form D page | Source |
| November 24, 2025 | Form D, private offering | $10.81M sold | Form D page | Source |
| October 10, 2025 | Form D, private offering | $1M sold | Form D page | Source |
| September 23, 2025 | Form D, private offering | $2.38M sold | Form D page | Source |
| May 28, 2025 | Form D, private offering | $1.50M sold | Form D page | Source |
| July 20, 2017 | Court case: Plant v. Jaguar Animal Health, Inc, District Court, N.D. California | — | Court records | Source |
Jaguar Health, Inc.: every filing and event
Tools for this story
Each opens in a new tab, filled in for Jaguar Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.